Anti-Mesothelin抗体[K1] (ab3362)

发表研究结果有使用 ab3362?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab3362 被引用在 7 文献中.

  • Wang K  et al. Inhibition of mesothelin as a novel strategy for targeting cancer cells. PLoS One 7:e33214 (2012). WB, Flow Cyt ; Human . PubMed: 22485139
  • Ren YR  et al. Structural Analysis of the Cancer-specific Promoter in Mesothelin and in Other Genes Overexpressed in Cancers. J Biol Chem 286:11960-9 (2011). WB ; Human . PubMed: 21288909
  • Tian Y  et al. Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics. Proteomics 11:4677-87 (2011). WB ; Human . PubMed: 22113853
  • Clayton A  et al. Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression. J Immunol 180:7249-58 (2008). WB, Flow Cyt ; Human . PubMed: 18490724
  • Li M  et al. Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther 7:286-96 (2008). Human . PubMed: 18281514
  • Clayton A  et al. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res 67:7458-66 (2007). PubMed: 17671216
  • Steinbach D  et al. Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells. Eur J Haematol 79:281-6 (2007). PubMed: 17803679

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"